Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 84, doi. 10.4103/1735-5362.251856
- By:
- Publication type:
- Article
Works matching IS 17355362 AND DT 2019 AND VI 14 AND IP 1
Results: 10
1
2
Searching for new cytotoxic agents based on chromen-4-one and chromane-2,4-dione scaffolds.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 74, doi. 10.4103/1735-5362.251855
- By:
- Publication type:
- Article
3
Effect of pentoxifylline on kidney damage induced by nitrosamine in male rats.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 64, doi. 10.4103/1735-5362.251854
- By:
- Publication type:
- Article
4
Pterostilbene increases Fas expression in T-lymphoblastic leukemia cell lines.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 55, doi. 10.4103/1735-5362.251853
- By:
- Publication type:
- Article
5
Acute and chronic effects of morphine on Low-Mg<sup>2+</sup> ACSF-induced epileptiform activity during infancy in mice hippocampal slices.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 46, doi. 10.4103/1735-5362.251852
- By:
- Publication type:
- Article
6
Regulatory effects of hemp seed/evening primrose oil supplement in comparison with rapamycin on the expression of the mammalian target of rapamycin-complex 2 and interleukin-10 genes in experimental autoimmune encephalomyelitis.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 36, doi. 10.4103/1735-5362.251851
- By:
- Publication type:
- Article
7
Cytotoxic effect of dual fluorescent-labeled oncolytic herpes simplex virus type 1 on mouse tumorigenic cell lines.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 27, doi. 10.4103/1735-5362.251850
- By:
- Publication type:
- Article
8
Design and molecular dynamic simulation of a new double-epitope tolerogenic protein as a potential vaccine for multiple sclerosis disease.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 20, doi. 10.4103/1735-5362.251849
- By:
- Publication type:
- Article
9
Mas receptor antagonist (A799) alters the renal hemodynamics responses to angiotensin II administration after renal moderate ischemia/reperfusion in rats: gender related differences.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 12, doi. 10.4103/1735-5362.251848
- By:
- Publication type:
- Article
10
Effect of cellulose derivative matrix and oligosaccharide on the solid state and physical characteristics of dimethyldioctadecylammonium-liposomes for vaccine.
- Published in:
- Research in Pharmaceutical Sciences, 2019, v. 14, n. 1, p. 1, doi. 10.4103/1735-5362.251847
- By:
- Publication type:
- Article